| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| NEUTRAL | BUY | NEUTRAL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.15▼ | 1.14▲ | 1.13▲ | 1.15▼ | 1.19▼ |
| MA10 | 1.14▲ | 1.13▲ | 1.13▲ | 1.15▼ | 1.29▼ |
| MA20 | 1.14▲ | 1.15▼ | 1.17▼ | 1.23▼ | 1.39▼ |
| MA50 | 1.17▼ | 1.24▼ | 1.28▼ | 1.35▼ | 1.33▼ |
| MA100 | 1.29▼ | 1.38▼ | 1.38▼ | 1.40▼ | 1.72▼ |
| MA200 | 1.37▼ | 1.39▼ | 1.40▼ | 1.41▼ | 2.68▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.005▲ | 0.009▲ | 0.008▲ | -0.003▼ | -0.037▼ |
| RSI | 47.831▼ | 40.881▼ | 40.165▼ | 38.872▼ | 41.596▼ |
| STOCH | 100.000▲ | 85.714▲ | 78.571 | 42.687 | 15.073▼ |
| WILL %R | 0.000▲ | 0.000▲ | 0.000▲ | -62.770 | -85.075▼ |
| CCI | 58.333 | 142.456▲ | 130.055▲ | -76.105 | -139.537▼ |
|
Sunday, August 09, 2026 08:11 AM
The latest lung cancer development represents a setback for one pathway rather than a verdict on the entire pipeline. Merck still has multiple programs moving through clinical and regulatory processes ...
|
|
Thursday, August 06, 2026 12:29 PM
Merck confronts an approaching Keytruda patent cliff and is broadening its pipeline across oncology, vaccines and cardiometabolic care to build fresh franchises before exclusivity ends. The company's ...
|
|
Tuesday, August 04, 2026 10:40 PM
Global pharmaceutical company Merck (NYSE:MRK) in Q2 CY2026, with sales up 5.1% year on year to $16.61 billion. The company expects the full year’s revenue to be around $66.8 billion, close to ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 10/08/26 | 1.10 | 1.15 | 1.10 | 1.15 | 48,617 |
| 07/08/26 | 1.14 | 1.14 | 1.11 | 1.12 | 39,990 |
| 06/08/26 | 1.18 | 1.25 | 1.12 | 1.12 | 29,316 |
| 05/08/26 | 1.265 | 1.265 | 1.10 | 1.14 | 102,986 |
| 04/08/26 | 1.24 | 1.28 | 1.23 | 1.23 | 30,845 |
| 03/08/26 | 1.16 | 1.31 | 1.16 | 1.22 | 61,777 |
| 31/07/26 | 1.15 | 1.20 | 1.11 | 1.13 | 37,436 |
| 30/07/26 | 1.11 | 1.14 | 1.05 | 1.12 | 72,414 |
| 29/07/26 | 1.1883 | 1.21 | 1.11 | 1.11 | 39,199 |
| 28/07/26 | 1.22 | 1.22 | 1.18 | 1.18 | 20,186 |
|
|
||||
|
|
||||
|
|